Concepedia

Antonino Musolino

AM

61

Publications

4.1K

Citations

28

H-Index

1996

Active since

Affiliations

University of Parma(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

University of Modena and Reggio Emilia

Istituto Oncologico Veneto

Antonino Musolino is an author at University of Parma specializing in medicine, oncology, and breast cancer.

Top concepts

MedicineOncologyBreast CancerRadiation OncologyCancer TherapyPathologyCancer ResearchClinical TrialsPharmacotherapyImmunology

Publications per year

1996–2025

61

Publications

61

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ <i>neu</i> –Positive Metastatic Breast Cancer

Antonino Musolino, Nadia Naldi, Beatrice Bortesi et al. · Journal of Clinical Oncology · 2008 · 949 citations · Full text

Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study

Valentina Guarneri, Antonio Frassoldati, Alberto Bottini et al. · Journal of Clinical Oncology · 2012 · 366 citations · Full text

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer

Hope S. Rugo, Seock‐Ah Im, Fátima Cardoso et al. · JAMA Oncology · 2021 · 336 citations · Full text

Inavolisib-Based Therapy in <i>PIK3CA</i> -Mutated Advanced Breast Cancer

Nicholas C. Turner, Seock‐Ah Im, Cristina Saura et al. · New England Journal of Medicine · 2024 · 178 citations

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

Pierfranco Conté, Antonio Frassoldati, Giancarlo Bisagni et al. · Annals of Oncology · 2018 · 152 citations · Full text

Rows per page

1–5 of 61